These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2183062)

  • 1. Twenty-five years with Cryptococcus neoformans.
    Bulmer GS
    Mycopathologia; 1990 Feb; 109(2):111-22. PubMed ID: 2183062
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of saprophytic Cryptococcus neoformans var. neoformans in Kinshasa, Zaïre.
    Swinne D; Kayembe K; Niyimi M
    Ann Soc Belg Med Trop; 1986; 66(1):57-61. PubMed ID: 3521504
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells.
    Murphy JW
    Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764
    [No Abstract]   [Full Text] [Related]  

  • 5. Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A.
    Bhattacharjee AK; Kwon-Chung KJ; Glaudemans CP
    Carbohydr Res; 1981 Sep; 95(2):237-48. PubMed ID: 7028261
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic differences among serotypes of Cryptococcus neoformans.
    Bennett JE; Kwon-Chung KJ; Howard DH
    Am J Epidemiol; 1977 Jun; 105(6):582-6. PubMed ID: 326036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F; Alture-Werber E
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
    Porter KG; Sinnamon DG; Gillies RR
    Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
    Diamond RD; Bennett JE
    J Infect Dis; 1973 Jun; 127(6):694-7. PubMed ID: 4575001
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcus neoformans: size range of infectious particles from aerosolized soil.
    Neilson JB; Fromtling RA; Bulmer GS
    Infect Immun; 1977 Sep; 17(3):634-8. PubMed ID: 332630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INFECTION OF WHITE SWISS MICE WITH AIRBORNE CRYPTOCOCCUS NEOFORMANS.
    SMITH CD; RITTER R; LARSH HW; FURCOLOW ML
    J Bacteriol; 1964 Jun; 87(6):1364-8. PubMed ID: 14188714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.
    Cogliati M; Puccianti E; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Rickerts V; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencà ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Boekhout T; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Colom MF
    Environ Microbiol; 2017 Oct; 19(10):4318-4325. PubMed ID: 28892309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of cyclosporine on interleukin-2 receptor expression stimulated by Cryptococcus neoformans.
    Miller GP; Lewis DE
    J Infect Dis; 1987 Apr; 155(4):799-802. PubMed ID: 3102632
    [No Abstract]   [Full Text] [Related]  

  • 17. First case of cryptococcosis in a new species of bandicoot (Bandicota indica) caused by Cryptococcus neoformans var. grubii.
    Singh SM; Naidu J; Sharma A; Nawange SR; Singh K
    Med Mycol; 2007 Feb; 45(1):89-93. PubMed ID: 17325950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the capsule in phagocytosis of Cryptococcus neoformans.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of Cryptococcus neoformans in soils.
    AJELLO L
    Am J Hyg; 1958 Jan; 67(1):72-7. PubMed ID: 13508655
    [No Abstract]   [Full Text] [Related]  

  • 20. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.